SB 265 Nevada Senate · 2017 Regular Session

Revises provisions relating to prescription drugs. (BDR 40-809)

Bill status vetoed 4 of 5 stages cleared

Introduction

Mar 2017

Committee Review

May 2017

Senate Passage

May 2017

Assembly Passage

May 2017

Vetoed

Jun 2017

Introduced Mar 14, 2017 Vetoed Jun 2, 2017

Floor votes · Assembly May 25, 2017

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jun 2, 2017

Vetoed

Vetoed by the Governor. Returned to Senate with Governor's veto message.

executive

May 25, 2017

Lower · Passed

Read third time. Passed. Title approved. (Yeas: 26, Nays: 14, Excused: 2.) To Senate.

lower

May 25, 2017

Lower · Passed

From committee: Do pass.

lower

May 19, 2017

Upper · Passed

Read third time. Passed, as amended. Title approved, as amended. (Yeas: 19, Nays: 2.)

upper

May 18, 2017

Upper · Passed

From committee: Amend, and do pass as amended.

upper

May 12, 2017

Upper · Passed

From printer. To engrossment. Engrossed. First reprint . To committee.

upper

May 11, 2017

Committee

Re-referred to Committee on Finance. To printer.

upper

May 9, 2017

Upper · Passed

From committee: Amend, and do pass as amended.

upper

Mar 15, 2017

Upper · Passed

From printer. To committee.

upper

4 primary · 6 co-sponsors